All Pharma News
Quince doses first patient in Phase 3 trial of EryDex for Ataxia-Telangiectasia

Quince doses first patient in Phase 3 trial of EryDex for Ataxia-Telangiectasia
BUSINESSWIRE
25 Jun 2024
Share Share
FDA fast tracks Quince Therapeutics’ rare ataxia drug EryDex

FDA fast tracks Quince Therapeutics’ rare ataxia drug EryDex
Jenna Philpott PHARMACEUTICAL TECHNOLOGY
04 Jun 2024
Share Share
Quince Therapeutics Receives U.S. FDA Fast Track Designation for EryDex System

Quince Therapeutics Receives U.S. FDA Fast Track Designation for EryDex System
BUSINESSWIRE
03 Jun 2024
Share Share
Quince Therapeutics Provides Update, Reports Q1 2024 Results

Quince Therapeutics Provides Update, Reports Q1 2024 Results
BUSINESSWIRE
13 May 2024
Share Share
Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference

Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference
BUSINESSWIRE
06 May 2024
Share Share
Quince Provides Business Update and Reports Q4 and Fiscal 2023 FR

Quince Provides Business Update and Reports Q4 and Fiscal 2023 FR
BUSINESSWIRE
01 Apr 2024
Share Share
Quince Therapeutics Launches Scientific Advisory Board

Quince Therapeutics Launches Scientific Advisory Board
BUSINESSWIRE
22 Feb 2024
Share Share
Quince Therapeutics Appoints Dr. Rajiv Patni to its Board of Directors

Quince Therapeutics Appoints Dr. Rajiv Patni to its Board of Directors
BUSINESSWIRE
15 Feb 2024
Share Share
Quince to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference

Quince to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
BUSINESSWIRE
07 Feb 2024
Share Share
Quince Therapeutics to Participate at Investor Events in January 2024

Quince Therapeutics to Participate at Investor Events in January 2024
BUSINESSWIRE
04 Jan 2024
Share Share